TYLOX-325 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tylox-325, and when can generic versions of Tylox-325 launch?
Tylox-325 is a drug marketed by Ortho Mcneil Pharm and is included in one NDA.
The generic ingredient in TYLOX-325 is acetaminophen; oxycodone hydrochloride. There are sixty-six drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the acetaminophen; oxycodone hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TYLOX-325?
- What are the global sales for TYLOX-325?
- What is Average Wholesale Price for TYLOX-325?
Summary for TYLOX-325
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 98 |
| DailyMed Link: | TYLOX-325 at DailyMed |
US Patents and Regulatory Information for TYLOX-325
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ortho Mcneil Pharm | TYLOX-325 | acetaminophen; oxycodone hydrochloride | CAPSULE;ORAL | 088246-001 | Nov 8, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
